Global Capecitabine Market Insights and Forecast to 2026 by Top Companies, Regions, Types and Applications
出 版 商：XYZ Research
出版日期：2019/12/01
頁 數：103頁
文件格式：PDF
價 格：
USD 2,760 (Single-User License)
USD 5,500 (Global-User License)
USD 5,500 (Global-User License)
In this report,global Capecitabine Market will reach 1031.47 Million USD by the end of 2022 with a CAGR of -0.17%
The global Capecitabine market is valued at 1040.38 Million USD in 2017 and will reach 1031.47 Million USD by the end of 2022, growing at a CAGR of -0.17% during 2017-2022.
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Capecitabine can be divided into two categories—500 mg type and 150 mg type. 500 mg type production market share accounted for the highest proportion, with a figure of 67.42% in 2017, regenerative type account for 32.58%.
The consumption market share of global Capecitabine in Breast Cancer use, Colorectal cancer use and Stomach Cancer use have been stable year by year, at 40.16%, 31.01% and 28.83% respectively in 2017, and for several consecutive years, the amplitude was within one percent. This indicates that the segment of the Capecitabine in the global market tends to be fixed without great changes. Among them, the Capecitabine market has the most promising sales prospects in Breast Cancer use.
XYZ research center data shows that North America is the biggest contributor to the Capecitabine revenue market, accounted for 54.53% of the total global market with a revenue of 567.37 million USD in 2017, followed by Europe, 28.92% with a revenue of 300.91 million USD.
Roche is the largest company in the global Capecitabine market, accounted for 62.81% of the revenue market share in 2017, followed by Teva and Mylan, accounted for 15.60% and 9.94% of the revenue market share in 2017. These manufacturers range from large multinational corporations to small privately owned companies compete in this industry. The top four producers account for above 90% of the revenue market.
All manufactures in the world are committed to the improvement of product. These two years, some of Chinese and India manufactures can almost catch up with the world's leading technology too. Most technologies are developed by the manufacturers instead of importing from other companies.
Geographically, global Capecitabine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Roche
Teva
Mylan
Hikma
Hengrui Medicine
Cipla
Reliance Group
Hetero
Other
On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
150mg
500mg
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Capecitabine for each application, including
Breast Cancer
Colorectal Cancer
Stomach Cancer
Production, consumption, revenue, market share and growth rate are the key targets for Capecitabine from 2014 to 2026 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
If you have any special requirements, please let us know and we will offer you the report as you want.
The global Capecitabine market is valued at 1040.38 Million USD in 2017 and will reach 1031.47 Million USD by the end of 2022, growing at a CAGR of -0.17% during 2017-2022.
Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
Capecitabine can be divided into two categories—500 mg type and 150 mg type. 500 mg type production market share accounted for the highest proportion, with a figure of 67.42% in 2017, regenerative type account for 32.58%.
The consumption market share of global Capecitabine in Breast Cancer use, Colorectal cancer use and Stomach Cancer use have been stable year by year, at 40.16%, 31.01% and 28.83% respectively in 2017, and for several consecutive years, the amplitude was within one percent. This indicates that the segment of the Capecitabine in the global market tends to be fixed without great changes. Among them, the Capecitabine market has the most promising sales prospects in Breast Cancer use.
XYZ research center data shows that North America is the biggest contributor to the Capecitabine revenue market, accounted for 54.53% of the total global market with a revenue of 567.37 million USD in 2017, followed by Europe, 28.92% with a revenue of 300.91 million USD.
Roche is the largest company in the global Capecitabine market, accounted for 62.81% of the revenue market share in 2017, followed by Teva and Mylan, accounted for 15.60% and 9.94% of the revenue market share in 2017. These manufacturers range from large multinational corporations to small privately owned companies compete in this industry. The top four producers account for above 90% of the revenue market.
All manufactures in the world are committed to the improvement of product. These two years, some of Chinese and India manufactures can almost catch up with the world's leading technology too. Most technologies are developed by the manufacturers instead of importing from other companies.
Geographically, global Capecitabine market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
Roche
Teva
Mylan
Hikma
Hengrui Medicine
Cipla
Reliance Group
Hetero
Other
On the basis of product, we research the production, revenue, price, market share and growth rate, primarily split into
150mg
500mg
For the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Capecitabine for each application, including
Breast Cancer
Colorectal Cancer
Stomach Cancer
Production, consumption, revenue, market share and growth rate are the key targets for Capecitabine from 2014 to 2026 (forecast) in these regions
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Report Overview
1.1 Definition
1.2 Manufacturers and Regions Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.4 Application Overview
1.5 Industrial Chain
1.5.1 Capecitabine Overall Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
1.5.4 Economic/Political Environment
2 Global Capecitabine Market Assesment by Types
2.1 Overall Market Performance
2.1.1 Product Type Market Performance (Volume)
2.1.2 Product Type Market Performance (Value)
2.2 China Capecitabine Market Performance
2.3 USA Capecitabine Market Performance
2.4 Europe Capecitabine Market Performance
2.5 Japan Capecitabine Market Performance
2.6 Korea Capecitabine Market Performance
2.7 India Capecitabine Market Performance
2.8 Southeast Asia Capecitabine Market Performance
2.9 South America Capecitabine Market Performance
3 Global Capecitabine Market Assesment by Application
3.1 Overall Market Performance (Volume)
3.2 China Capecitabine Market Performance (Volume)
3.3 USA Capecitabine Market Performance (Volume)
3.4 Europe Capecitabine Market Performance (Volume)
3.5 Japan Capecitabine Market Performance (Volume)
3.6 Korea Capecitabine Market Performance (Volume)
3.7 India Capecitabine Market Performance (Volume)
3.8 Southeast Asia Capecitabine Market Performance (Volume)
3.9 South America Capecitabine Market Performance (Volume)
4 Competitive Analysis
4.1 Roche
4.1.1 Roche Profiles
4.1.2 Roche Product Information
4.1.3 Roche Capecitabine Production, Revenue, Price and Gross Margin
4.1.4 Roche Capecitabine Business Performance
4.1.5 SWOT Analysis
4.2 Teva
4.2.1 Teva Profiles
4.2.2 Teva Product Information
4.2.3 Teva Capecitabine Production, Revenue, Price and Gross Margin
4.2.4 Teva Capecitabine Business Performance
4.2.5 SWOT Analysis
4.3 Mylan
4.3.1 Mylan Profiles
4.3.2 Mylan Product Information
4.3.3 Mylan Capecitabine Production, Revenue, Price and Gross Margin
4.3.4 Mylan Capecitabine Business Performance
4.3.5 SWOT Analysis
4.4 Hikma
4.4.1 Hikma Profiles
4.4.2 Hikma Product Information
4.4.3 Hikma Capecitabine Production, Revenue, Price and Gross Margin
4.4.4 Hikma Capecitabine Business Performance
4.4.5 SWOT Analysis
4.5 Hengrui Medicine
4.5.1 Hengrui Medicine Profiles
4.5.2 Hengrui Medicine Product Information
4.5.3 Hengrui Medicine Capecitabine Production, Revenue, Price and Gross Margin
4.5.4 Hengrui Medicine Capecitabine Business Performance
4.5.5 SWOT Analysis
4.6 Cipla
4.6.1 Cipla Profiles
4.6.2 Cipla Product Information
4.6.3 Cipla Capecitabine Production, Revenue, Price and Gross Margin
4.6.4 Cipla Capecitabine Business Performance
4.6.5 SWOT Analysis
4.7 Reliance Group
4.7.1 Reliance Group Profiles
4.7.2 Reliance Group Product Information
4.7.3 Reliance Group Capecitabine Production, Revenue, Price and Gross Margin
4.7.4 Reliance Group Capecitabine Business Performance
4.7.5 SWOT Analysis
4.8 Hetero
4.8.1 Hetero Profiles
4.8.2 Hetero Product Information
4.8.3 Hetero Capecitabine Production, Revenue, Price and Gross Margin
4.8.4 Hetero Capecitabine Business Performance
4.8.5 SWOT Analysis
4.9 Other
4.9.1 Other Profiles
4.9.2 Other Product Information
4.9.3 Other Capecitabine Production, Revenue, Price and Gross Margin
4.9.4 Other Capecitabine Business Performance
4.9.5 SWOT Analysis
5 Competitive Landscape
5.1 Global Capecitabine Production (K Units) and Market Share by Manufacturers (2014-2020)
5.2 Global Capecitabine Revenue (M USD) and Market Share by Manufacturers (2014-2020)
5.3 Global Capecitabine Price (USD/Unit) of Manufacturers (2014-2020)
5.4 Global Capecitabine Gross Margin of Manufacturers (2014-2020)
5.5 Market Concentration
6 Global Capecitabine Market Assessment by Regions
6.1 Global Capecitabine Production (K Units) and Market Share by Regions (2014-2020)
6.2 Global Capecitabine Revenue (M USD) and Market Share by Regions (2014-2020)
6.3 Global Capecitabine Price (USD/Unit) by Regions (2014-2020)
6.4 Global Capecitabine Gross Margin by Regions (2014-2020)
7 Capecitabine Regional Analysis
7.1 China Capecitabine Production, Revenue and Growth Rate (2014-2020)
7.2 USA Capecitabine Production, Revenue and Growth Rate (2014-2020)
7.3 Europe Capecitabine Production, Revenue and Growth Rate (2014-2020)
7.4 Japan Capecitabine Production, Revenue and Growth Rate (2014-2020)
7.5 Korea Capecitabine Production, Revenue and Growth Rate (2014-2020)
7.6 India Capecitabine Production, Revenue and Growth Rate (2014-2020)
7.7 Southeast Asia Capecitabine Production, Revenue and Growth Rate (2014-2020)
7.8 South America Capecitabine Production, Revenue and Growth Rate (2014-2020)
8 Global Capecitabine Consumption Assessment
8.1 Global Capecitabine Consumption and Market Share by Regions (2014-2020)
8.2 Global Capecitabine Consumption Value and Market Share by Regions (2014-2020)
8.3 Global Capecitabine Average Price (USD/Unit) by Regions (2014-2020)
9 Global Capecitabine Sales Assessment by Regions
9.1 Global Capecitabine Sales and Sales Value (2014-2020)
9.2 China Capecitabine Sales and Sales Value (2014-2020)
9.3 USA Capecitabine Sales and Sales Value (2014-2020)
9.4 Europe Capecitabine Sales and Sales Value (2014-2020)
9.5 Japan Capecitabine Sales and Sales Value (2014-2020)
9.6 Korea Capecitabine Sales and Sales Value (2014-2020)
9.7 India Capecitabine Sales and Sales Value (2014-2020)
9.8 Southeast Asia Capecitabine Sales and Sales Value (2014-2020)
9.9 South America Capecitabine Sales and Sales Value (2014-2020)
10 Technology and Cost
10.1 Technology
10.2 Cost
11 Channel Analysis
11.1 Market Channel
11.2 Distributors
12 Market Forecast 2021-2026
12.1 Production and Revenue Forecast 2021-2026
12.1.1 Global Capecitabine Production and Revenue by Regions 2021-2026
12.1.2 China Capecitabine Production, Revenue and Growth Rate 2021-2026
12.1.3 USA Capecitabine Production, Revenue and Growth Rate 2021-2026
12.1.4 Europe Capecitabine Production, Revenue and Growth Rate 2021-2026
12.1.5 Japan Capecitabine Production, Revenue and Growth Rate 2021-2026
12.1.6 Korea Capecitabine Production, Revenue and Growth Rate 2021-2026
12.1.7 India Capecitabine Production, Revenue and Growth Rate 2021-2026
12.1.8 Southeast Asia Capecitabine Production, Revenue and Growth Rate 2021-2026
12.1.9 South America Capecitabine Production, Revenue and Growth Rate 2021-2026
12.2 Sales and Sales Value Forecast 2021-2026
12.2.1 Global Capecitabine Consumption and Consumption Calue by Regions 2021-2026
12.2.2 Global Capecitabine Sales and Sales Value Forecast 2021-2026
12.2.3 China Capecitabine Sales, Sales Value and Growth Rate 2021-2026
12.2.4 USA Capecitabine Sales and Sales Value Forecast 2021-2026
12.2.5 Europe Capecitabine Sales and Sales Value Forecast 2021-2026
12.2.6 Japan Capecitabine Sales and Sales Value Forecast 2021-2026
12.2.7 Korea Capecitabine Sales and Sales Value Forecast 2021-2026
12.2.8 India Capecitabine Sales and Sales Value Forecast 2021-2026
12.2.9 Southeast Asia Capecitabine Sales and Sales Value Forecast 2021-2026
12.2.10 South America Capecitabine Sales and Sales Value Forecast 2021-2026
12.3 Global Capecitabine Production and Revenue Forecast by Type 2021-2026
12.3.1 Overall Market Performance
12.3.2 150mg
12.3.3 500mg
12.4 Global Capecitabine Sales Forecast by Application 2021-2026
12.4.1 Overall Market Performance
12.4.2 Breast Cancer
12.4.3 Colorectal Cancer
12.4.4 Stomach Cancer
12.5 Global Capecitabine Price and Gross Margin Forecast
13.5.1 Global Capecitabine Averages Price Development Trend Forecast 2021-2026
13.5.2 Global Capecitabine Gross Margin Development Trend Forecast 2021-2026
13 Conclusion
1 Report Overview
1.1 Definition
1.2 Manufacturers and Regions Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.4 Application Overview
1.5 Industrial Chain
1.5.1 Capecitabine Overall Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
1.5.4 Economic/Political Environment
2 Global Capecitabine Market Assesment by Types
2.1 Overall Market Performance
2.1.1 Product Type Market Performance (Volume)
2.1.2 Product Type Market Performance (Value)
2.2 China Capecitabine Market Performance
2.3 USA Capecitabine Market Performance
2.4 Europe Capecitabine Market Performance
2.5 Japan Capecitabine Market Performance
2.6 Korea Capecitabine Market Performance
2.7 India Capecitabine Market Performance
2.8 Southeast Asia Capecitabine Market Performance
2.9 South America Capecitabine Market Performance
3 Global Capecitabine Market Assesment by Application
3.1 Overall Market Performance (Volume)
3.2 China Capecitabine Market Performance (Volume)
3.3 USA Capecitabine Market Performance (Volume)
3.4 Europe Capecitabine Market Performance (Volume)
3.5 Japan Capecitabine Market Performance (Volume)
3.6 Korea Capecitabine Market Performance (Volume)
3.7 India Capecitabine Market Performance (Volume)
3.8 Southeast Asia Capecitabine Market Performance (Volume)
3.9 South America Capecitabine Market Performance (Volume)
4 Competitive Analysis
4.1 Roche
4.1.1 Roche Profiles
4.1.2 Roche Product Information
4.1.3 Roche Capecitabine Production, Revenue, Price and Gross Margin
4.1.4 Roche Capecitabine Business Performance
4.1.5 SWOT Analysis
4.2 Teva
4.2.1 Teva Profiles
4.2.2 Teva Product Information
4.2.3 Teva Capecitabine Production, Revenue, Price and Gross Margin
4.2.4 Teva Capecitabine Business Performance
4.2.5 SWOT Analysis
4.3 Mylan
4.3.1 Mylan Profiles
4.3.2 Mylan Product Information
4.3.3 Mylan Capecitabine Production, Revenue, Price and Gross Margin
4.3.4 Mylan Capecitabine Business Performance
4.3.5 SWOT Analysis
4.4 Hikma
4.4.1 Hikma Profiles
4.4.2 Hikma Product Information
4.4.3 Hikma Capecitabine Production, Revenue, Price and Gross Margin
4.4.4 Hikma Capecitabine Business Performance
4.4.5 SWOT Analysis
4.5 Hengrui Medicine
4.5.1 Hengrui Medicine Profiles
4.5.2 Hengrui Medicine Product Information
4.5.3 Hengrui Medicine Capecitabine Production, Revenue, Price and Gross Margin
4.5.4 Hengrui Medicine Capecitabine Business Performance
4.5.5 SWOT Analysis
4.6 Cipla
4.6.1 Cipla Profiles
4.6.2 Cipla Product Information
4.6.3 Cipla Capecitabine Production, Revenue, Price and Gross Margin
4.6.4 Cipla Capecitabine Business Performance
4.6.5 SWOT Analysis
4.7 Reliance Group
4.7.1 Reliance Group Profiles
4.7.2 Reliance Group Product Information
4.7.3 Reliance Group Capecitabine Production, Revenue, Price and Gross Margin
4.7.4 Reliance Group Capecitabine Business Performance
4.7.5 SWOT Analysis
4.8 Hetero
4.8.1 Hetero Profiles
4.8.2 Hetero Product Information
4.8.3 Hetero Capecitabine Production, Revenue, Price and Gross Margin
4.8.4 Hetero Capecitabine Business Performance
4.8.5 SWOT Analysis
4.9 Other
4.9.1 Other Profiles
4.9.2 Other Product Information
4.9.3 Other Capecitabine Production, Revenue, Price and Gross Margin
4.9.4 Other Capecitabine Business Performance
4.9.5 SWOT Analysis
5 Competitive Landscape
5.1 Global Capecitabine Production (K Units) and Market Share by Manufacturers (2014-2020)
5.2 Global Capecitabine Revenue (M USD) and Market Share by Manufacturers (2014-2020)
5.3 Global Capecitabine Price (USD/Unit) of Manufacturers (2014-2020)
5.4 Global Capecitabine Gross Margin of Manufacturers (2014-2020)
5.5 Market Concentration
6 Global Capecitabine Market Assessment by Regions
6.1 Global Capecitabine Production (K Units) and Market Share by Regions (2014-2020)
6.2 Global Capecitabine Revenue (M USD) and Market Share by Regions (2014-2020)
6.3 Global Capecitabine Price (USD/Unit) by Regions (2014-2020)
6.4 Global Capecitabine Gross Margin by Regions (2014-2020)
7 Capecitabine Regional Analysis
7.1 China Capecitabine Production, Revenue and Growth Rate (2014-2020)
7.2 USA Capecitabine Production, Revenue and Growth Rate (2014-2020)
7.3 Europe Capecitabine Production, Revenue and Growth Rate (2014-2020)
7.4 Japan Capecitabine Production, Revenue and Growth Rate (2014-2020)
7.5 Korea Capecitabine Production, Revenue and Growth Rate (2014-2020)
7.6 India Capecitabine Production, Revenue and Growth Rate (2014-2020)
7.7 Southeast Asia Capecitabine Production, Revenue and Growth Rate (2014-2020)
7.8 South America Capecitabine Production, Revenue and Growth Rate (2014-2020)
8 Global Capecitabine Consumption Assessment
8.1 Global Capecitabine Consumption and Market Share by Regions (2014-2020)
8.2 Global Capecitabine Consumption Value and Market Share by Regions (2014-2020)
8.3 Global Capecitabine Average Price (USD/Unit) by Regions (2014-2020)
9 Global Capecitabine Sales Assessment by Regions
9.1 Global Capecitabine Sales and Sales Value (2014-2020)
9.2 China Capecitabine Sales and Sales Value (2014-2020)
9.3 USA Capecitabine Sales and Sales Value (2014-2020)
9.4 Europe Capecitabine Sales and Sales Value (2014-2020)
9.5 Japan Capecitabine Sales and Sales Value (2014-2020)
9.6 Korea Capecitabine Sales and Sales Value (2014-2020)
9.7 India Capecitabine Sales and Sales Value (2014-2020)
9.8 Southeast Asia Capecitabine Sales and Sales Value (2014-2020)
9.9 South America Capecitabine Sales and Sales Value (2014-2020)
10 Technology and Cost
10.1 Technology
10.2 Cost
11 Channel Analysis
11.1 Market Channel
11.2 Distributors
12 Market Forecast 2021-2026
12.1 Production and Revenue Forecast 2021-2026
12.1.1 Global Capecitabine Production and Revenue by Regions 2021-2026
12.1.2 China Capecitabine Production, Revenue and Growth Rate 2021-2026
12.1.3 USA Capecitabine Production, Revenue and Growth Rate 2021-2026
12.1.4 Europe Capecitabine Production, Revenue and Growth Rate 2021-2026
12.1.5 Japan Capecitabine Production, Revenue and Growth Rate 2021-2026
12.1.6 Korea Capecitabine Production, Revenue and Growth Rate 2021-2026
12.1.7 India Capecitabine Production, Revenue and Growth Rate 2021-2026
12.1.8 Southeast Asia Capecitabine Production, Revenue and Growth Rate 2021-2026
12.1.9 South America Capecitabine Production, Revenue and Growth Rate 2021-2026
12.2 Sales and Sales Value Forecast 2021-2026
12.2.1 Global Capecitabine Consumption and Consumption Calue by Regions 2021-2026
12.2.2 Global Capecitabine Sales and Sales Value Forecast 2021-2026
12.2.3 China Capecitabine Sales, Sales Value and Growth Rate 2021-2026
12.2.4 USA Capecitabine Sales and Sales Value Forecast 2021-2026
12.2.5 Europe Capecitabine Sales and Sales Value Forecast 2021-2026
12.2.6 Japan Capecitabine Sales and Sales Value Forecast 2021-2026
12.2.7 Korea Capecitabine Sales and Sales Value Forecast 2021-2026
12.2.8 India Capecitabine Sales and Sales Value Forecast 2021-2026
12.2.9 Southeast Asia Capecitabine Sales and Sales Value Forecast 2021-2026
12.2.10 South America Capecitabine Sales and Sales Value Forecast 2021-2026
12.3 Global Capecitabine Production and Revenue Forecast by Type 2021-2026
12.3.1 Overall Market Performance
12.3.2 150mg
12.3.3 500mg
12.4 Global Capecitabine Sales Forecast by Application 2021-2026
12.4.1 Overall Market Performance
12.4.2 Breast Cancer
12.4.3 Colorectal Cancer
12.4.4 Stomach Cancer
12.5 Global Capecitabine Price and Gross Margin Forecast
13.5.1 Global Capecitabine Averages Price Development Trend Forecast 2021-2026
13.5.2 Global Capecitabine Gross Margin Development Trend Forecast 2021-2026
13 Conclusion
